Clinical trials: Algoneurodystrophy, open to volunteers
Algoneurodystrophy
Thrombotic RIsk FActors in AL-goneurodystrophy
The primary objective of the study is to evaluate the prevalence of blood prothrombotic factors in CRPS patients and their role in predicting response to neridronic acid treatment.
- Trial name
- TRIF-AL (NCT07435207)
- Where
- Italy
- Volunteers
- 120 people
- Sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia